15 Vaccine Development Companies From around the world

Tip: Select a quick entry below to view selected vaccine development companies by company type, industry or country.

15 Vaccine Development Companies From around the world

Tip: Select a quick entry below to view selected vaccine development companies by company type, industry or country.

image description

AstriVax NV

Service, Pharma, Heverlee, Belgium

AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax has secured a seed round of € 30 million with a strong investor syndicate to continue building the vaccine technology platform and bring the first ...

vaccine development vaccines
image description

CimCure

Service, Biotechnology, Amsterdam, Netherlands

CimCure is a 2016 spin-off from Amsterdam UMC. CimCure focuses on the design and development of a novel class of active cancer immunotherapies. The company develops cancer vaccines through its proprietary Immune-Boost (iBoost) technology of targeted conjugate vaccines. They have identified ...

vaccine development cancer vaccines
image description

Defence Therapeutics

Service, Biotechnology, Vancouver, Canada

Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in ...

vaccine development
image description

Frame Cancer Therapeutics

Service, Biotechnology, Amsterdam, Netherlands

Frame Cancer Therapeutics is a privately funded startup company in the Amsterdam Science Park founded in December 2018. Frame Therapeutics’ goal is to develop its proprietary approach for immunotherapy against cancer, which is based on precise analysis of the DNA and RNA of the tumor of a patient ...

vaccine development cancer vaccines
image description

Imophoron Ltd

Manufacturer, Biotechnology, Bristol, United Kingdom

Imophoron was founded in 2017 and is based at Science Creates in Bristol, UK. Imophoron has developed a novel next-generation nanoparticle platform, ADDomer™, initially focused on the development of vaccines to combat present and future infectious diseases, including ‘Disease X’ outbreaks. ...

vaccine development vaccines
image description

LimmaTech Biologics AG

Service, Biotechnology, Schlieren, Switzerland

LimmaTech Biologics AG is a Swiss clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antimicrobial resistance (AMR) and sexually transmitted diseases. LimmaTech was founded in 2015 as a ...

vaccine development
image description

Nouscom AG

Manufacturer, Biotechnology, Basel, Switzerland

Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an ...

vaccine development cancer therapeutics therapeutic vaccines
image description

PRiME Vector Technologies GmbH

Manufacturer, Biotechnology, Tübingen, Germany

The Challenge: Companies in the vaccine industry are facing the challenge of producing highly effective customized vaccines in a quick and cost-effective way, both, in the fields of oncology and infectious diseases. Currently, neither is possible with the common platforms due to excessive ...

vaccine development coronaviruses vaccines
image description

RocketVax AG

Manufacturer, Biotechnology, Basel, Switzerland

The company brings together both scientific and operational expertise from various institutions in Switzerland and Germany and aims to become a world leading centre of excellence for novel vaccine development. RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator ...

vaccine development live vaccines
image description

Themis Bioscience GmbH

Service, Biotechnology, Wien, Austria

Themis Bioscience is an international biotech company that successfully develops vaccines against emerging and specialist indications. Exploiting the full potential of our proprietary Themaxyn® platform we are able to identify and rapidly advance vaccine candidates at various stages of ...

vaccine development therapeutic vaccines
Search all

These products might interest you

Tangential Flow Filtration (TFF) Solutions

Tangential Flow Filtration (TFF) Solutions by Sartorius

Tangential Flow Filtration Systems

Process Solutions for Ultrafiltration and Diafiltration

filtration systems
View product
Biacore catalogue

Biacore catalogue by Cytiva

Get started with Surface Plasmon Resonance interaction analysis - which system is right for you?

Discover simpler and faster Surface Plasmon Resonance (SPR) with Biacore systems

View product
Show all vaccine development
Haven't found the right company yet?

The bionity.com company search

Start your targeted search now with a wide selection of filter options. Our database includes 8,840 life science companies from all over the world. Here you can easily find the right provider for your search, including contact options.

Start company search now